Serum vaccine antibody concentrations in children exposed to perfluorinated compounds
- PMID: 22274686
- PMCID: PMC4402650
- DOI: 10.1001/jama.2011.2034
Serum vaccine antibody concentrations in children exposed to perfluorinated compounds
Erratum in
- JAMA. 2012 Mar 21;307(11):1142
Abstract
Context: Perfluorinated compounds (PFCs) have emerged as important food contaminants. They cause immune suppression in a rodent model at serum concentrations similar to those occurring in the US population, but adverse health effects of PFC exposure are poorly understood.
Objective: To determine whether PFC exposure is associated with antibody response to childhood vaccinations.
Design, setting, and participants: Prospective study of a birth cohort from the National Hospital in the Faroe Islands. A total of 656 consecutive singleton births were recruited during 1997-2000, [corrected] and 587 participated in follow-up through 2008.
Main outcome measures: Serum antibody concentrations against tetanus and diphtheria toxoids at ages 5 and 7 years.
Results: Similar to results of prior studies in the United States, the PFCs with the highest serum concentrations were perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). Among PFCs in maternal pregnancy serum, PFOS showed the strongest negative correlations with antibody concentrations at age 5 years, for which a 2-fold greater concentration of exposure was associated with a difference of -39% (95% CI, -55% to -17%) in the diphtheria antibody concentration. PFCs in the child's serum at age 5 years showed uniformly negative associations with antibody levels, especially at age 7 years, except that the tetanus antibody level following PFOS exposure was not statistically significant. In a structural equation model, a 2-fold greater concentration of major PFCs in child serum was associated with a difference of -49% (95% CI, -67% to -23%) in the overall antibody concentration. A 2-fold increase in PFOS and PFOA concentrations at age 5 years was associated with odds ratios between 2.38 (95% CI, 0.89 to 6.35) and 4.20 (95% CI, 1.54 to 11.44) for falling below a clinically protective level of 0.1 IU/mL for tetanus and diphtheria antibodies at age 7 years.
Conclusion: Elevated exposures to PFCs were associated with reduced humoral immune response to routine childhood immunizations in children aged 5 and 7 years.
Figures
Comment in
-
Perfluorinated compounds and immunotoxicity in children.JAMA. 2012 May 9;307(18):1910; author reply 1910-1. doi: 10.1001/jama.2012.3599. JAMA. 2012. PMID: 22570452 No abstract available.
Similar articles
-
Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.J Immunotoxicol. 2017 Dec;14(1):188-195. doi: 10.1080/1547691X.2017.1360968. J Immunotoxicol. 2017. PMID: 28805477 Free PMC article.
-
[Persistant perfluorinated compounds cause immunotoxic effects].Ugeskr Laeger. 2014 Feb 24;176(9A):V09130572. Ugeskr Laeger. 2014. PMID: 25350410 Review. Danish.
-
Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.Environ Health Perspect. 2017 Jul 26;125(7):077018. doi: 10.1289/EHP275. Environ Health Perspect. 2017. PMID: 28749778 Free PMC article.
-
Perfluorinated compounds and immunotoxicity in children.JAMA. 2012 May 9;307(18):1910; author reply 1910-1. doi: 10.1001/jama.2012.3599. JAMA. 2012. PMID: 22570452 No abstract available.
-
Perfluorinated substances in human food and other sources of human exposure.Rev Environ Contam Toxicol. 2010;208:179-215. doi: 10.1007/978-1-4419-6880-7_4. Rev Environ Contam Toxicol. 2010. PMID: 20811865 Review.
Cited by
-
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety.Comput Struct Biotechnol J. 2024 Jul 1;23:2763-2778. doi: 10.1016/j.csbj.2024.06.036. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39050784 Free PMC article.
-
Emerging contaminants: A One Health perspective.Innovation (Camb). 2024 Mar 13;5(4):100612. doi: 10.1016/j.xinn.2024.100612. eCollection 2024 Jul 1. Innovation (Camb). 2024. PMID: 38756954 Free PMC article. Review.
-
One pot application of a green chemistry-based finish for cotton fabric, providing hydrophobic, flame retardant, and antimicrobial properties.RSC Adv. 2024 Feb 19;14(9):6146-6155. doi: 10.1039/d3ra07931g. eCollection 2024 Feb 14. RSC Adv. 2024. PMID: 38375009 Free PMC article.
-
Association of per- and polyfluoroalkyl substances (PFAS) with periodontitis: the mediating role of sex hormones.BMC Oral Health. 2024 Feb 15;24(1):243. doi: 10.1186/s12903-024-03863-0. BMC Oral Health. 2024. PMID: 38360594 Free PMC article.
-
Prenatal Exposure to Poly- and Perfluoroalkyl Substances (2009-2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort.Environ Health Perspect. 2023 Dec;131(12):127018. doi: 10.1289/EHP12863. Epub 2023 Dec 26. Environ Health Perspect. 2023. PMID: 38147368 Free PMC article.
References
-
- Vestergren R, Cousins IT. Tracking the pathways of human exposure to perfluorocarboxylates. Environ Sci Technol. 2009;43(15):5565–5575. - PubMed
-
- Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) Environ Sci Technol. 2007;41(7):2237–2242. - PubMed
-
- European Food Safety Authority Opinion of the Scientific Panel on Contaminants in the Food Chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. EFSA J. 2008;653:1–131. http://www.efsa.europa.eu/de/scdocs/doc/653.pdf. Accessed December 29, 2011. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous